Purpose: The study aims to develop and validate algorithms to identify and classify opioid overdoses using claims and other coded data, and clinical text extracted from electronic health records using natural language processing (NLP).
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| INTRODUCTION
Opioid use disorders and fatal and nonfatal opioid-related overdoses (OODs) are significant public health problems. [1] [2] [3] [4] [5] [6] [7] [8] Initiatives to reduce prescription opioid-related risks include clinical guidelines, 9 restricted access to extended-release/long-acting (ER/LA) opioids, [10] [11] [12] added abuse-deterrent properties, [13] [14] [15] FDA's Risk Evaluation and Mitigation Strategies (REMS), [16] [17] [18] [19] opioid management plans, 10, 20, 21 and state prescription drug monitoring programs. [22] [23] [24] Accurate identification of OODs is essential to quantify the burden of the problem, evaluate risk-reduction strategies, monitor population-level outcomes, and
improve prevention and quality of care. Furthermore, differentiation of type, such as suicides or heroin-related overdoses, is needed to target and evaluate specific interventions.
To date, few studies have validated methods used to identify
OODs. [25] [26] [27] [28] The purpose of this study was to improve upon and conduct a full validation of a previously developed algorithm to identify overdose events 26 and to develop and validate algorithms that classify types of overdoses (eg, heroin-related and suicides). The original study was limited in scope, excluding events that occurred within 3 days of surgery, and only assessed positive predictive value (PPV). The present study attempted to improve algorithm performance using (a) additional coded data, including a sample of individuals without identified 
| Samples
Mutually exclusive samples were constructed for development and validation. Suspected OOD cases composed approximately 56% of each sample, defined by a patient and a point in time (based on ICD9-CM/ ICD10-CM codes), using the previously developed OOD algorithm (the "OOD algorithm"; Table 1 ) and opioid-related adverse effects codes. The remainder of each sample (approximately 44%) consisted of "at-risk" individuals likely to have an OOD but for whom no suspected OODs were identified. Individuals at risk were identified using diagnoses commonly comorbid with opioid/other substance use disorders. Diagnoses were chosen on the basis of prior research and existing literature and included the following: (a) substance abuse diagnoses, (b) mental health diagnoses, and (c) diagnoses associated with substance abuse (see Data S1). Individuals with at least two diagnoses from two categories, without suspected OODs, were considered at risk.
We drew stratified random samples of at-risk individuals, half with 0-29 days' supply of ER/LA opioids in the prior year, and half with greater than or equal to 30 days' supply. At-risk periods were converted to events/nonevents for analyses.
| Development sample
We created the development sample first, using OOD cases previously identified, to maximize information available for development.
Cases included events identified using opioid-related International Classification of Diseases, Ninth/Tenth Revisions (ICD-9/10) poisoning codes and opioid-related adverse effects codes. We included the latter to provide information that would help differentiate OODs from adverse effects. Together, these codes together formed the "suspected overdose" stratum in the sample.
| Validation sample
We randomly selected algorithm-identified OOD events and at-risk individuals not used in development, proportionate to the number of suspected overdoses (approximately 56%) and at-risk cases (approximately 44%) in that sample. This "balancing" allowed performance comparisons between development and validation samples. Once development was complete, performance was assessed in the validation sample.
| Datasets
The 
| Chart audit process
Chart audit data were considered the "gold standard" against which algorithm results were compared. Index dates were dates of suspected OODs or, for those at risk, dates of the second qualifying diagnosis.
We examined clinical records of at-risk patients for overdoses for a 
| Algorithm performance standards
Algorithm performance was evaluated using sensitivity, specificity, PPV, NPV, and F-scores. No universal standards exist for sensitivity or specificity because acceptability depends on context and use.
We expected OODs and heroin involvement to be readily identifiable, thus set sensitivity and specificity of 85% as acceptable and 90% as excellent for these algorithms. We expected other classifications (abuse, suicides/attempts, misuse, polysubstance involvement, and medication error) to be more difficult, thus set 75% as acceptable for sensitivity/specificity. F-scores measure the accuracy of the algorithm and vary from 0 to 1, with 1 representing perfect fit. We considered F-score values of 0.90 or greater to indicate excellent performance. Chi-square tests assessed differences between performance in development and validation datasets.
| Code-based algorithm development procedures
We used the least absolute shrinkage and selection operator (LASSO) regression 29, 30 to select variables based on predicted probabilities of case status, and classification and regression trees (CART) with random forest (500 trees) 31 to evaluate cutoff values for continuous
KEY POINTS
• OODs can be identified using coded insurance claims data or electronic health records.
• Heroin-involved OODs can be accurately identified.
• OODs that are suicides/suicide attempts can be identified with adequate accuracy using coded data.
• OODs involving substance abuse can be identified with adequate accuracy using coded data.
• Algorithms for classifying suicides/suicide attempts and substance abuse-involved overdoses can be significantly improved using data derived from natural language processing of clinical text in electronic health records.
variables. Variables selected using LASSO were entered into logistic regression analyses to estimate final parameters. Predicted probabilities from logistic regression analyses were used to classify events.
Parameters were then applied to the validation dataset and compared with chart audit findings.
| OOD algorithm
We began by forcing the ICD-9/10 codes from our prior algorithm 26 into the model ( None improved performance. The best fitting model used a binary variable coded "1" if any ICD-9/10 codes listed in Table 1 were found.
| OODs with heroin involvement
Among chart-audit-confirmed OODs in the development sample (n = 423), codes shown in Table 3 were tested to predict heroin involvement. The best fitting model performed well, and used a binary variable coded "1" if E965.01, E850.0, or T40.1 were present.
| Suicides/suicide attempt-related OODs
We modeled overdoses in the development sample (n = 423) according to whether or not they were suicides/attempted suicides (see Tables 4 and 5 for codes evaluated). The initial model assessed predictors identified in the Mental Health Research Network's work predicting suicides/suicide attempts. 32 We created a binary variable if any suicide-related codes in Table 4 were present, binary variables for single or multiple episode depression diagnoses, and interaction terms for suicide and recurrent depression. Next, we tested diagnoses Though the study period was prior to the nationwide switch to ICD-10 diagnostic codes, ICD-10 cause-of-death codes were in use nationwide throughout the study period. for alcohol use disorders, anxiety disorders, bipolar disorders, tobacco and drug use disorders, other psychoses, and schizophrenia spectrum disorders ( 
| Substance use involved unintentional OODs
For unintentional overdoses (n = 268), we developed an algorithm to detect substance abuse involvement, using logistic regression to evaluate diagnostic codes listed in Table 6 . The final model included two terms: (a) a binary indicator of substance abuse coded "1" if any ICD-9 code related to heroin was present, or if there were no dispenses for an ER/LA or IR opioid in the year prior to the overdose (including the event date), and (b) indication of opioid abuse from ICD-9 codes in the 2 years prior to the event. 
| NLP-enhanced algorithm development
We attempted to enhance code-based algorithm performance with indicators extracted using NLP of EHR clinical notes. The companion paper (Hazlehurst et al 33 ) provides details about development and validation of NLP-derived variables. Each NLP-derived variable was tested using logistic regression analyses to determine whether or not its addition improved performance beyond that of each respective code-based algorithm. We used DeLong's test for two correlated receiver operator curves to compare areas under the curve for codebased and NLP-enhanced models. Table 7 shows definitions of NLP-derived binary variables to codebased algorithms for testing. The NLP classification "polysubstance including opioid" was broken into six binary subcomponents: named opioids; general "narcotics"; named opioid-interacting medications;
named recreational/illicit drugs; alcohol; named over-the-counter medications. The NLP classification "substance abuse" was broken into two subcomponents: alcohol or substance abuse noted; alcohol presence mentioned. dataset had a slightly higher prevalence of heroin-involved OODs than the development dataset (16.2% vs. 11.8%) and similar prevalence of intentional overdoses (36.6% development and 34.2% validation), and substance use involved unintentional overdoses (41.4% and 43.7%, respectively). The study protocol was reviewed and approved by all sites' institutional review boards.
| Portability assessment
3 | RESULTS Table 8 summarizes algorithm performance in development and validation datasets for algorithms reaching acceptable performance during development. The OOD algorithm performed well: sensitivity (97.2%), specificity (84.6%), PPV (87.4%), and NPV (96.5%).
There were no differences between development and validation datasets on sensitivity, PPV, or NPV, though specificity declined.
The heroin-involved classification also performed well in validation:
sensitivity was 91.8%, specificity 99.0%, PPV 94.7%, and NPV 98.4%. Some measures of performance (specificity and PPV) were significantly (P ≤ 0.018) better in the validation compared with the development dataset (Table 8) .
For the classification identifying suicides/suicide attempts, performance was acceptable for the code-based model in both datasets and did not differ significantly (P ≥ 0.142) between the two. Sensitivity was 70.5%, specificity 90.2%, PPV 78.9%, and NPV 85.5% for the coded-based algorithm.
Performance of the code-based classification for substance abuseinvolved OODs was also acceptable: Sensitivity was 75.3%, specificity 79.5%, PPV 74.0%, and NPV 80.5%. Performance did not differ between development and validation datasets (P ≥ 0.117).
Models classifying opioid misuse, patient medication errors, and polysubstance involvement did not reach acceptable (greater than or equal to 0.75%) levels of sensitivity and specificity so were not validated. We identified few events involving clinician error and few inpatient events making modeling unfeasible for these classifications.
For inpatient overdose/oversedation, we adopted a different identification strategy (see Green et al, companion paper 34 ).
| NLP-enhanced models
The addition of NLP variables did not improve performance of the code-based OOD algorithm or the heroin algorithm, though NLPenhanced models outperformed code-based models for classifying suicides/suicide attempts (sensitivity = 78.7%, specificity = 91.0%, PPV = 81.9%, and NPV = 89.2%) and those involving substance abuse (sensitivity = 80.5%, specificity = 76.3%, PPV = 72.5%, and NPV = 83.4%). Performance declined for the NLP-enhanced models in the validation dataset compared with the development dataset (Table 8 ), but validation results remained above acceptable limits for suicides/suicide attempts and substance abuse-involved overdoses for sensitivity, specificity, and NPV.
3.2 | Algorithm portability performance further investigation, it appeared that chart audit determinations for substance abuse-related OODs at these two sites were made difficult by data limitations.
| DISCUSSION
The code-based OOD algorithm, using ICD-9 diagnostic codes and death data using ICD-10 codes, has excellent performance across health systems, whether applied to EHR-based databases or commercial or Medicaid claims databases. Few inpatient events were identified using the algorithm, suggesting that it does not confound inpatient overdoses that are typically medically related with accidental or intentional overdoses occurring elsewhere. Given the excellent performance of the code-based OOD algorithm, the NLP-enhanced algorithm was unable to improve performance.
In short, our results show that a simple code-based algorithm can be used to accurately identify overdoses in widely differing settings.
Similarly, the code-based algorithm classifying overdoses as heroininvolved showed excellent performance across settings when adequate numbers of heroin-related events were available for testing.
As with the OOD algorithm, however, there was little room from improved performance in an NLP-enhanced model.
Identifying suicides/attempted suicides presented a greater challenge, though the code-based algorithm performed adequately.
Performance was not as good at Optum or TennCare, but PPV and NPV were acceptable in all but TennCare, where reviews were focused on inpatient health care encounters rather than both inpatient and outpatient data. Other sites had access to OOD-related follow-up visits that often provided information necessary to determine when an OOD was a suicide/suicide attempt. The NLP-enhanced algorithm significantly improved performance for detecting suicides/suicide attempts suggesting that including NLP-derived data from clinical notes is beneficial when available. Performance of the NLP-enhanced model was good in both sites with the necessary data. suggest that using NLP to identify substance abuse-involved overdoses will be more fruitful than code-based algorithms alone.
As a result of limited cases for some classifications, we were unsuccessful with code-based or NLP-enhanced models classifying prescription medication misuse or patient errors. Other limitations included that development was based primarily on data extracted from a single integrated health care system. Portability assessments designed to overcome this limitation provide important confirmation for some outcomes but limitations in sample sizes and data sources at portability sites made some comparisons unfeasible. Also, NLPenhanced algorithms rely on a specific NLP system (MediClass) for extracting information from clinical notes. Although the "knowledge"
used by MediClass is easily extracted for use by other NLP systems, results may not be identical.
| CONCLUSIONS
To 
